Paul G. Allen Frontiers Group    [to 7 Mar 2020]
Press Release
Competition yields new approaches to trace development, cell by cell
March 4, 2020
The Allen Institute and Sage Bionetworks announced winners of the Allen Institute Cell Lineage Reconstruction DREAM Challenge
BMGF – Gates Foundation  [to 7 Mar 2020]
MARCH 04, 2020
Bill & Melinda Gates Foundation Commits $5 Million to Help Public Health Agencies in Greater Seattle Area Respond to COVID-19
SEATTLE March 4, 2020 – The Bill & Melinda Gates Foundation announced today that it will commit an additional $5 million to help public health agencies in the greater Seattle region enhance their capacity to detect novel coronavirus (COVID-19) in King County, Snohomish County and other surrounding communities.
Bill & Melinda Gates Medical Research Institute    [to 7 Mar 2020]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
CARB-X   [to 7 Mar 2020]
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.
CEPI – Coalition for Epidemic Preparedness Innovations  [to 7 Mar 2020]
CEPI welcomes UK Government’s funding and highlights need for $2 billion to develop a vaccine against COVID-19
06 Mar 2020
[See COVID-19 above for detail]
Clinton Health Access Initiative, Inc. (CHAI)  [to 7 Mar 2020]
News & Press Releases
No new digest content identified.
EDCTP    [to 7 Mar 2020]
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
3 March 2020
International research partnership and EDCTP to invest €44 million in next-generation antimalarials to combat drug-resistant malaria in Africa
:: EDCTP grants the PAMAfrica research consortium €21.9 million over a five year period; MMV, Novartis and other partners will provide an additional €22 million.
:: The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new medicines for both severe and uncomplicated malaria, designed to combat emerging artemisinin resistance.
:: The projects will include the development of the first new malaria treatment for babies under 5kg, a new fast-acting medicine for the treatment of severe malaria, and new combinations to treat drug-resistant uncomplicated malaria

PDF version

Emory Vaccine Center    [to 7 Mar 2020]
No new digest content identified.
European Medicines Agency  [to 7 Mar 2020]
News & Press Releases
No new digest content identified.

European Vaccine Initiative  [to 7 Mar 2020]
No new digest content identified.

FDA [to 7 Mar 2020]
Press Announcements
March 2, 2020 – Coronavirus (COVID-19) Update: FDA and CDC take action to increase access to respirators, including N95s, for health care personnel

Today, in a joint effort, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention took action to make more respirators, including certain N95s, available to health care personnel. Currently, the majority of respirators on the market are indicated for use in industrial settings. Today’s action allows certain National Institute for Occupational Safety and Health (NIOSH) approved respirators not currently regulated by the FDA to be used in a health care setting by health care personnel during the coronavirus (COVID-19) outbreak, thereby maximizing the number of respirators available to meet the needs of the U.S. health care system…

Fondation Merieux  [to 7 Mar 2020]
News, Events
No new digest content identified.

Gavi [to 7 Mar 2020]
No new digest content identified.
GHIT Fund   [to 7 Mar 2020]
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.
Global Fund  [to 7 Mar 2020]

News & Stories

Feature Story
COVID-19 Threatens the Poor and Marginalized More than Anyone
06 March 2020
Feature Story
Women Leading the Fight for Better Health
06 March 2020
Sourcing & Management of Health Products
COVID-19 Impact on Supply Chain Logistics
06 March 2020
The global response to control the outbreak of the new coronavirus, COVID-19, may influence health product supply chains including logistics and shipping, as almost all finished health products or ingredients used in health products originate from China.
As a precautionary measure, we recommend that all Global Fund implementing partners place orders 30 days earlier than normal to better manage any disturbances that may emerge in being able to deliver products on-time…
Global Fund Issues New Guidance in Response to COVID-19
04 March 2020
GENEVA – The Global Fund announced today new guidance to enable countries to strengthen their response to the new coronavirus, COVID-19, by using existing grants in a swift, nimble and pragmatic way.
Working within its mandate to fight HIV, TB and malaria and to strengthen systems for health, the Global Fund is encouraging countries to reprogram savings from existing grants and to redeploy underutilized resources to mitigate the potential negative consequences of COVID-19 on health and health systems. In exceptional cases, countries may be able to reprogram funding from existing grants to COVID-19 response…


Hilleman Laboratories   [to 7 Mar 2020]
No new digest content identified.

Human Vaccines Project   [to 7 Mar 2020]
Press Releases
No new digest content identified.

IAVI  [to 7 Mar 2020]
March 5, 2020
IAVI and Batavia Biosciences Announce Collaboration on VSV-vector Based Epidemic Preparedness Vaccines

Mutual expertise drives innovations to address supply issues for vaccines for outbreak pathogens

NEW YORK — MARCH 5, 2020 — IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges, and Batavia Biosciences, a contract development and manufacturing organization focused on delivering sustainable manufacturing solutions in the field of infectious disease and cancer, today announced their partnership to accelerate the development of vaccines for emerging infectious diseases (EIDs).

By working with Batavia Biosciences to leverage their state-of-the-art manufacturing approach for highly intensified, modular vaccine production, IAVI intends to develop an end-to-end platform for flexible, low-cost production of epidemic preparedness vaccines, including vaccines against a group of viruses that cause hemorrhagic fevers and other emerging viral disease threats. Importantly, collaborating on these vaccines and developing the platform will also enable these two institutions to accelerate the development of a vaccine candidate to address the rapidly growing coronavirus disease (COVID-19) outbreak…
International Coalition of Medicines Regulatory Authorities [ICMRA]
Selected Statements, Press Releases, Research
No new digest content identified.
International Generic and Biosimilar Medicines Association [IGBA]
No new digest content identified.
No new digest content identified.
IFRC   [to 7 Mar 2020]
Selected Press Releases, Announcements
Europe, Greece, Turkey
Greece-Turkey Border: Migrants must not be used as a political tool. The EU and Member States must act in solidarity now.
Geneva/Budapest, 3 March 2020 – Women, children and men caught up in the ongoing humanitarian crisis at the land border between Greece and Turkey, in the Greek islands and in the Aegean Sea must not be “used as a political tool”, the International Fede …
3 March 2020
IVAC  [to 7 Mar 2020]
No new digest content identified.
IVI   [to 7 Mar 2020]
Selected IVI News & Announcements
International Vaccine Institute and Technical University of Denmark to strengthen external quality assurance in the face of rising antimicrobial resistance in Asia
:: The Asia Pacific region is vulnerable to the emergence and spread of AMR but there is little high-quality data available on the extent of its impact
:: Quality-assured data is essential for building tailored strategies for preventing the spread of drug-resistant infections
:: IVI is part of three active Fleming Fund Regional Grants to enhance surveillance and close gaps in confronting the growing challenges of AMR in low- and middle-income countries
March 5, 2020, SEOUL, Korea – The International Vaccine Institute (IVI) and the Technical University of Denmark’s (DTU) National Food Institute announced today a joint effort to strengthen external quality assurance programs for diagnostic laboratories in Asia to confront the challenges of rising antimicrobial resistance (AMR) in the region. The partnership was established following the award of a Fleming Fund Regional Grant with DTU as the lead grantee and will carry out the project under the name EQASIA (Strengthening External Quality Assurance for AMR in Asia)…
JEE Alliance  [to 7 Mar 2020]
Selected News and Events
No new digest content identified.
MSF/Médecins Sans Frontières  [to 7 Mar 2020]
Latest [Selected Announcements]
Port-au-Prince: Over 360 people admitted for lifesaving care in three months …
Project Update 6 Mar 2020
Non-communicable diseases
Why are so many women dying of cervical cancer?
Project Update 5 Mar 2020
Afghans face impossible choices in their struggle for medical care
Press Release 5 Mar 2020
Reality check: Afghanistan’s neglected healthcare crisis
Report 5 Mar 2020
EU must address migration emergency as Greek islands reach bre…
Statement 4 Mar 2020
Social violence and exclusion
Violence in southwestern Colombia leaves people struggling to access ass…
Statement 3 Mar 2020
South Sudan
Thousands flee into the bush as conflict intensifies in east South…
Statement 2 Mar 2020
People in northwestern Syria forced to move as frontlines move
Voices from the Field 2 Mar 2020
Arbitrary detention in Libya must end as asylum seeker dies in d…
Press Release 2 Mar 2020
National Vaccine Program Office – U.S. HHS  [to 7 Mar 2020]
NVAC 2020 Meetings
June 9-10, 2020 NVAC Meeting
September 23-24, 2020 Meeting (Virtual)

NIH  [to 7 Mar 2020]
Selected News Releases
Selected Announcements
No new digest content identified.
PATH  [to 7 Mar 2020]
Selected Announcements
No new digest content identified.
Sabin Vaccine Institute  [to 7 Mar 2020]
Statements and Press Releases
Sabin Vaccine Institute Strengthens Ebola Sudan and Marburg Vaccines Program with Additional NIAID Partnership
Thursday, March 5, 2020
WASHINGTON, D.C. – The Sabin Vaccine Institute (Sabin) today announced that it has partnered with the Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases (NIAID), to manufacture prototype ChAd3 vectored Ebola Sudan and Marburg vaccines to be used for further clinical evaluation and outbreak preparedness and to potentially protect military, first responders, health care and laboratory workers, and other at-risk populations. Sabin will receive $5.3 million to manufacture Ebola Sudan and Marburg vaccines for the VRC…
UNAIDS [to 7 Mar 2020]
Selected Press Releases/Reports/Statements
6 March 2020
HIV data check in Papua New Guinea’s National Capital District
5 March 2020
Community project helps families respond to stigma and discrimination
Raising the voices of women at the forefront of climate change
3 March 2020
Breaking the vicious cycle of HIV-related stigma in Tajikistan
Hollaback! Jakarta working to end harassment against women
Decriminalization works, but too few countries are taking the bold step
2 March 2020
Services tailored for women who inject drugs in India
UNICEF  [to 7 Mar 2020]
Statement by Charlotte Petri Gornitzka, UNICEF Deputy Executive Director for Partnerships, on coronavirus misinformation
NEW YORK, 6 March 2020 – “All around the world, people are taking necessary precautions to protect themselves and their families from coronavirus. Sound preparation, based on scientific evidence, is what is needed at this time.
“However, while many people are sharing information about the virus and how to protect against it, only some of that information is useful or reliable. Misinformation during times of a health crisis can spread paranoia, fear, and stigmatization. It can also result in people being left unprotected or more vulnerable to the virus.
“For example, a recent erroneous online message circulating in several languages around the world and purporting to be a UNICEF communication appears to indicate, among other things, that avoiding ice cream and other cold foods can help prevent the onset of the disease. This is, of course, wholly untrue.
“To the creators of such falsehoods, we offer a simple message: STOP. Sharing inaccurate information and attempting to imbue it with authority by misappropriating the names of those in a position of trust is dangerous and wrong.
“To members of the public, we ask that you seek accurate information about how to keep yourself and your family safe from verified sources, such as UNICEF or WHO, government health officials and trusted healthcare professionals; and that you refrain from sharing information from untrustworthy or unverified sources…
Press release
Panama sees more than seven-fold increase in number of migrant children crossing through Darien Gap
Nearly 24,000 people from more than 50 nationalities, 16 per cent of whom are children, crossed the dangerous jungle in 2019
Press release
UNICEF, WFP chiefs wrap up two-day visit to Syria, see impact of conflict on children and families
UN officials call for cessation of hostilities and protection of children as conflict is about to enter its 10th year
Press release
25 years of uneven progress: Despite gains in education, world still a violent, highly discriminatory place for girls
Two and a half decades after the historic Beijing women’s conference, violence against women and girls still not only common, but accepted
Protecting children must be top priority, in latest refugee surge response
Statement by Ms. Afshan Khan, UNICEF Regional Director for Europe and Central Asia and Special Coordinator for the Refugee and Migrant Response in Europe
Press release
Lack of quality data compounds risks facing millions of refugee and migrant children
UNICEF, IOM, UNHCR, OECD, countries and other partners join forces to protect children through the International Data Alliance on Children on the Move
Press release
UN releases $15 million to help vulnerable countries battle the spread of the coronavirus
[See COVID-19 above for detail]
Vaccination Acceptance Research Network (VARN)  [to 7 Mar 2020]
No new digest content identified.
Vaccine Confidence Project  [to 7 Mar 2020]
Latest News & Archive
No new digest content identified.
Vaccine Education Center – Children’s Hospital of Philadelphia  [to 7 Mar 2020]
No new digest content identified.
Wellcome Trust  [to 7 Mar 2020]
Opinion | 4 March 2020
Lab leaders must create open and safe spaces to improve research culture
by Ricardo Henriques
The Wistar Institute   [to 7 Mar 2020]
Press Releases
No new digest content identified.
World Organisation for Animal Health (OIE)   [to 7 Mar 2020]
Press Releases
No new digest content identified.


ARM [Alliance for Regenerative Medicine]  [to 7 Mar 2020]
Press Releases
The Alliance for Regenerative Medicine Releases 2019 Annual Report and Sector Year in Review
March 5, 2020
BIO    [to 7 Mar 2020]
Press Releases
BIO Asia Conference in Tokyo Cancelled Amid COVID-19 Outbreak
Washington, DC – February 21, 2020 – The Biotechnology Innovation Organization (BIO) announced today, it is canceling the annual BIO Asia conference in Tokyo scheduled for March 10-11. The decision was based on the global impact of COVID-19 and Japanese government recommendations.
“Our attendees’ health and safety are our utmost priority,” said Jim Greenwood, BIO President & CEO. “We offer our support and sympathy to all of those who’ve been impacted by the virus around the world.”…
DCVMN – Developing Country Vaccine Manufacturers Network  [to 7 Mar 2020]
No new digest content identified.
IFPMA   [to 7 Mar 2020]
Selected Press Releases, Statements, Publications
No new digest content identified.
PhRMA    [to 7 Mar 2020]
Selected Press Releases, Statements
ICYMI: Continued biopharmaceutical action on COVID-19
Andrew Powaleny   |     March 6, 2020
This week, PhRMA and senior executives and researchers from four member companies met with key policy makers on Capitol Hill to discuss the industry’s response to COVID-19, caused by a novel strain of coronavirus. Daniel O’Day of Gilead Sciences, Julie Louise Gerberding, M.D., M.P.H. of Merck & Co., Inc, Paul Stoffels, M.D. of Johnson & Johnson, John Shiver, Ph.D. of Sanofi Pasteur and Steve Ubl of PhRMA were crucial contributors to the dialogue and offered updates and insights on their companies’ and the industry’s progress in the fight against the coronavirus…